KR840004081A - 설포닐 우레아의 제조방법 - Google Patents

설포닐 우레아의 제조방법 Download PDF

Info

Publication number
KR840004081A
KR840004081A KR1019830001070A KR830001070A KR840004081A KR 840004081 A KR840004081 A KR 840004081A KR 1019830001070 A KR1019830001070 A KR 1019830001070A KR 830001070 A KR830001070 A KR 830001070A KR 840004081 A KR840004081 A KR 840004081A
Authority
KR
South Korea
Prior art keywords
substituted
carbon atoms
alkyl
salt
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
KR1019830001070A
Other languages
English (en)
Korean (ko)
Inventor
히쩰(외 3) 볼커
Original Assignee
하인리히 벡커 베른하르트 벡크
훽스트 아크티엔 게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 하인리히 벡커 베른하르트 벡크, 훽스트 아크티엔 게젤샤프트 filed Critical 하인리히 벡커 베른하르트 벡크
Publication of KR840004081A publication Critical patent/KR840004081A/ko
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
KR1019830001070A 1982-03-19 1983-03-17 설포닐 우레아의 제조방법 Abandoned KR840004081A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3210063,9 1982-03-19
DE19823210063 DE3210063A1 (de) 1982-03-19 1982-03-19 Sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung

Publications (1)

Publication Number Publication Date
KR840004081A true KR840004081A (ko) 1984-10-06

Family

ID=6158708

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830001070A Abandoned KR840004081A (ko) 1982-03-19 1983-03-17 설포닐 우레아의 제조방법

Country Status (12)

Country Link
EP (1) EP0089597A3 (enExample)
JP (1) JPS58170760A (enExample)
KR (1) KR840004081A (enExample)
AU (1) AU1266383A (enExample)
DE (1) DE3210063A1 (enExample)
DK (1) DK125583A (enExample)
ES (1) ES520706A0 (enExample)
FI (1) FI830898A7 (enExample)
GR (1) GR77163B (enExample)
NO (1) NO830966L (enExample)
PT (1) PT76411B (enExample)
ZA (1) ZA831910B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7087758B2 (en) * 2001-04-06 2006-08-08 Smithkline Beecham Corporation Quinoline inhibitors of hyaki and hyak3 kinases
KR101983979B1 (ko) 2010-08-27 2019-05-30 그뤼넨탈 게엠베하 Ｋｃｎｑ２／３ 조절제로서의 치환된 ２-옥소- 및 ２-티옥소-디하이드로퀴놀린-３-카복스아미드
TWI522349B (zh) 2010-08-27 2016-02-21 歌林達股份有限公司 作為ｋｃｎｑ２／３調節劑之被取代之２－氧基－喹啉－３－甲醯胺
CA2804824A1 (en) 2010-08-27 2012-03-01 Gruenenthal Gmbh Substituted quinoline-3-carboxamides as kcnq2/3 modulators
AU2011295406B2 (en) 2010-08-27 2015-08-06 Grunenthal Gmbh Substituted 2-amino-quinoline-3-carboxamides as KCNQ2/3 modulators
AU2011297937B2 (en) 2010-09-01 2015-10-01 Grunenthal Gmbh Substituted 1-oxo-dihydroisoquinoline-3-carboxamides as KCNQ2/3 modulators
CN105073738B (zh) * 2013-01-31 2018-01-05 沃泰克斯药物股份有限公司 作为钠通道调节剂的喹啉及喹喔啉酰胺类

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3819633A (en) * 1970-04-01 1974-06-25 Erba Carlo Spa (iso)quinolyl sulfonylureas having antidiabetic activity
DE2621958A1 (de) * 1976-05-18 1977-12-08 Hoechst Ag Benzolsulfonylharnstoffe und verfahren zu ihrer herstellung
DE3134780A1 (de) * 1981-09-02 1983-03-10 Hoechst Ag, 6000 Frankfurt "sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung"

Also Published As

Publication number Publication date
GR77163B (enExample) 1984-09-10
ES8401946A1 (es) 1984-01-01
FI830898L (fi) 1983-09-20
DE3210063A1 (de) 1983-09-22
EP0089597A3 (de) 1984-05-09
FI830898A7 (fi) 1983-09-20
PT76411A (de) 1983-04-01
AU1266383A (en) 1983-09-22
EP0089597A2 (de) 1983-09-28
FI830898A0 (fi) 1983-03-17
JPS58170760A (ja) 1983-10-07
ZA831910B (en) 1983-11-30
PT76411B (de) 1985-12-16
NO830966L (no) 1983-09-20
ES520706A0 (es) 1984-01-01
DK125583D0 (da) 1983-03-18
DK125583A (da) 1983-09-20

Similar Documents

Publication Publication Date Title
KR850006386A (ko) 아졸류의 제조방법
KR840003602A (ko) 인다닐벤즈아미드 유도체의 제조방법
KR840004081A (ko) 설포닐 우레아의 제조방법
KR840001138A (ko) 설포닐우레아의 제조방법
KR830005191A (ko) 푸란유도체의 제조방법
KR850004470A (ko) 유기 화합물의 제조방법
KR870003078A (ko) N-설파밀-3-(2-구아니디노-티아졸-4-일-메틸티오)프로피온아미딘의 제조방법
KR840007564A (ko) 치환된 벤질사이클로알케닐우레아 유도체의 제조방법
KR850005830A (ko) 2-알콕시아미노설포닐벤젠-설포닐우레아의 제조방법
KR850002979A (ko) 1,2,3-트리티안화합물의 신규 제조방법
KR860002486A (ko) 티아진포스폰산 유도체의 제조방법
KR830005165A (ko) 알킬 설폰의 제조방법
KR840002821A (ko) N-(2,3-에폭시프로필렌)-n-아르알킬술폰아미드 유도체의 제조방법
KR840005721A (ko) 치환된 1,3,4-벤조트리아제핀의 제조방법
KR850002974A (ko) 설펜아마이드 유도체의 제조방법
KR870007908A (ko) 인덴류 화합물의 제조방법
KR840004087A (ko) 트리아진 화합물의 조성물 및 이의 제조방법
KR910006276A (ko) 술포닐 우레아계 제초제의 새로운 제조방법
KR840004727A (ko) 설피닐-및 설포닐-아자 사이클로헵탄-2-온의 제조방법
KR840004418A (ko) N-설페닐화된 카바메이트의 제조방법
KR870002093A (ko) 설포닐이소(티오) 우레아의 제조방법
KR830009018A (ko) 아미노설페닐 클로라이드 유도체 및 카바메이트 유도체의 제조방법
KR860007215A (ko) 벤조아미드 유도체의 제조방법
KR840004086A (ko) 1,3,5-트리아크릴일헥사하이드로-s-트리아진-유도체의 제조방법
KR850006933A (ko) 설파모일-치환된 펜에틸아민 유도체의 제조방법

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19830317

PG1501 Laying open of application
PC1902 Submission of document of abandonment before decision of registration
SUBM Surrender of laid-open application requested